BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $415,000 | -10.4% | 10,278 | +40.9% | 0.01% | 0.0% |
Q2 2022 | $463,000 | -55.5% | 7,296 | -45.6% | 0.01% | -48.1% |
Q1 2022 | $1,040,000 | -7.3% | 13,418 | +2.6% | 0.03% | -6.9% |
Q4 2021 | $1,122,000 | +17.4% | 13,072 | +9.8% | 0.03% | 0.0% |
Q3 2021 | $956,000 | +28.5% | 11,900 | +28.9% | 0.03% | +26.1% |
Q2 2021 | $744,000 | +2.6% | 9,231 | +7.3% | 0.02% | -4.2% |
Q1 2021 | $725,000 | -4.5% | 8,600 | -9.1% | 0.02% | -22.6% |
Q4 2020 | $759,000 | +10.5% | 9,458 | +10.8% | 0.03% | -8.8% |
Q3 2020 | $687,000 | -23.7% | 8,535 | -18.3% | 0.03% | -27.7% |
Q2 2020 | $900,000 | +32.4% | 10,453 | +24.8% | 0.05% | +4.4% |
Q1 2020 | $680,000 | +81.3% | 8,375 | +86.9% | 0.04% | +95.7% |
Q4 2019 | $375,000 | -25.1% | 4,481 | -21.8% | 0.02% | -47.7% |
Q3 2019 | $501,000 | +22.2% | 5,727 | +14.3% | 0.04% | +33.3% |
Q2 2019 | $410,000 | -4.7% | 5,012 | -5.3% | 0.03% | +43.5% |
Q1 2019 | $430,000 | -64.0% | 5,293 | -70.9% | 0.02% | -65.7% |
Q4 2018 | $1,195,000 | +85.8% | 18,163 | +117.8% | 0.07% | +168.0% |
Q3 2018 | $643,000 | +34.8% | 8,340 | +16.5% | 0.02% | +31.6% |
Q1 2018 | $477,000 | -86.6% | 7,159 | -87.0% | 0.02% | -88.1% |
Q4 2017 | $3,563,000 | +1.5% | 55,117 | -1.4% | 0.16% | -15.8% |
Q3 2017 | $3,509,000 | +1089.5% | 55,921 | +1048.3% | 0.19% | +691.7% |
Q2 2017 | $295,000 | -6.1% | 4,870 | -19.5% | 0.02% | -22.6% |
Q1 2017 | $314,000 | -87.5% | 6,052 | -89.4% | 0.03% | -89.9% |
Q4 2016 | $2,520,000 | -14.4% | 56,836 | -8.1% | 0.31% | -21.7% |
Q3 2016 | $2,945,000 | -14.6% | 61,863 | -18.9% | 0.39% | -19.4% |
Q2 2016 | $3,449,000 | -50.2% | 76,261 | -54.8% | 0.48% | +13.6% |
Q1 2016 | $6,928,000 | +209.3% | 168,650 | +187.2% | 0.43% | +50.9% |
Q4 2015 | $2,240,000 | +114.6% | 58,721 | +84.8% | 0.28% | +95.2% |
Q3 2015 | $1,044,000 | +34.0% | 31,773 | +185.3% | 0.14% | +39.4% |
Q2 2015 | $779,000 | +11.8% | 11,138 | +9.5% | 0.10% | -25.7% |
Q1 2015 | $697,000 | – | 10,173 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |